Caricamento...
P04.22 Diffusivity changes in bevacizumab-responding and refractory meningioma
Introduction: Meningiomas may be highly vascularized and therefore respond to antiangiogenic treatment such as bevacizumab (Bev). Here we report on the time course of diffusivity as surrogate of tumor cell density and ischemic tissue changes in a patient with multiple intra- and extracranial meningi...
Salvato in:
| Pubblicato in: | Neuro Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463860/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.162 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|